ID

34967

Descrizione

HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT02061423

collegamento

https://clinicaltrials.gov/show/NCT02061423

Keywords

versioni (1)
  1. 06/02/19 06/02/19 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

6 febbraio 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Breast Cancer NCT02061423

Inglese

Eligibility Breast Cancer NCT02061423

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
women ≥ 18 years.
Descrizione

Gender | Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
subjects with her-2 expressing stage i - iii breast cancer with residual disease in the breast or axillary nodes post-neoadjuvant chemotherapy.
Descrizione

HER2-positive carcinoma of breast TNM Breast tumor staging | Residual Tumor Breast | Residual Tumor Axillary lymph nodes | Status post Chemotherapy Neoadjuvant

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1960398
UMLS CUI [1,2]
C0474926
UMLS CUI [2,1]
C0543478
UMLS CUI [2,2]
C0006141
UMLS CUI [3,1]
C0543478
UMLS CUI [3,2]
C0729594
UMLS CUI [4,1]
C0231290
UMLS CUI [4,2]
C0392920
UMLS CUI [4,3]
C0600558
women of childbearing age with a negative pregnancy serum test documented prior to enrollment.
Descrizione

Childbearing Potential Serum pregnancy test negative

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0430061
subjects with ecog performance status score of 0 or 1.
Descrizione

ECOG performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
women of childbearing potential must agree to use a medically acceptable form of birth control (medically accepted methods: birth control pills, condoms and spermicidal lubricants, intrauterine device, and diaphragm) during their participation in the study.
Descrizione

Childbearing Potential Contraceptive methods | Contraceptives, Oral | Female Condoms | Lubricants Spermicidal | Intrauterine Devices | Vaginal contraceptive diaphragm

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [2]
C0009905
UMLS CUI [3]
C0221829
UMLS CUI [4,1]
C0282222
UMLS CUI [4,2]
C0419533
UMLS CUI [5]
C0021900
UMLS CUI [6]
C0042241
subjects who have voluntarily signed a written informed consent in accordance with institutional policies after its contents have been fully explained to them.
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or lactating females.
Descrizione

Pregnancy | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
subjects with positive hiv or hepatitis c at baseline by self report.
Descrizione

HIV Seropositivity | Hepatitis C positive

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C1112419
subjects with coagulopathies, including thrombocytopenia with platelet count <75,000, inr > 1.5 and partial thromboplastin time > 50 sec.
Descrizione

Blood Coagulation Disorders | Thrombocytopenia | Platelet Count measurement | International Normalized Ratio | Partial thromboplastin time finding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0005779
UMLS CUI [2]
C0040034
UMLS CUI [3]
C0032181
UMLS CUI [4]
C0525032
UMLS CUI [5]
C1531697
subjects with muga < 50% ef.
Descrizione

Cardiac ejection fraction MUGA

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0232174
UMLS CUI [1,2]
C0521317
subjects with pre-existing medical illnesses or medications which might interfere with the study as determined by pi.
Descrizione

Pre-existing condition Interferes with Clinical Trial | Pharmaceutical Preparations Interfere with Clinical Trial

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0521987
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0008976
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0008976
Ritorna all'inizio della pagina

Similar models

Eligibility Breast Cancer NCT02061423

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
women ≥ 18 years.
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
HER2-positive carcinoma of breast TNM Breast tumor staging | Residual Tumor Breast | Residual Tumor Axillary lymph nodes | Status post Chemotherapy Neoadjuvant
Item
subjects with her-2 expressing stage i - iii breast cancer with residual disease in the breast or axillary nodes post-neoadjuvant chemotherapy.
boolean
C1960398 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
C0543478 (UMLS CUI [2,1])
C0006141 (UMLS CUI [2,2])
C0543478 (UMLS CUI [3,1])
C0729594 (UMLS CUI [3,2])
C0231290 (UMLS CUI [4,1])
C0392920 (UMLS CUI [4,2])
C0600558 (UMLS CUI [4,3])
Childbearing Potential Serum pregnancy test negative
Item
women of childbearing age with a negative pregnancy serum test documented prior to enrollment.
boolean
C3831118 (UMLS CUI [1,1])
C0430061 (UMLS CUI [1,2])
ECOG performance status
Item
subjects with ecog performance status score of 0 or 1.
boolean
C1520224 (UMLS CUI [1])
Childbearing Potential Contraceptive methods | Contraceptives, Oral | Female Condoms | Lubricants Spermicidal | Intrauterine Devices | Vaginal contraceptive diaphragm
Item
women of childbearing potential must agree to use a medically acceptable form of birth control (medically accepted methods: birth control pills, condoms and spermicidal lubricants, intrauterine device, and diaphragm) during their participation in the study.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0009905 (UMLS CUI [2])
C0221829 (UMLS CUI [3])
C0282222 (UMLS CUI [4,1])
C0419533 (UMLS CUI [4,2])
C0021900 (UMLS CUI [5])
C0042241 (UMLS CUI [6])
Informed Consent
Item
subjects who have voluntarily signed a written informed consent in accordance with institutional policies after its contents have been fully explained to them.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnant or lactating females.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
HIV Seropositivity | Hepatitis C positive
Item
subjects with positive hiv or hepatitis c at baseline by self report.
boolean
C0019699 (UMLS CUI [1])
C1112419 (UMLS CUI [2])
Blood Coagulation Disorders | Thrombocytopenia | Platelet Count measurement | International Normalized Ratio | Partial thromboplastin time finding
Item
subjects with coagulopathies, including thrombocytopenia with platelet count <75,000, inr > 1.5 and partial thromboplastin time > 50 sec.
boolean
C0005779 (UMLS CUI [1])
C0040034 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0525032 (UMLS CUI [4])
C1531697 (UMLS CUI [5])
Cardiac ejection fraction MUGA
Item
subjects with muga < 50% ef.
boolean
C0232174 (UMLS CUI [1,1])
C0521317 (UMLS CUI [1,2])
Pre-existing condition Interferes with Clinical Trial | Pharmaceutical Preparations Interfere with Clinical Trial
Item
subjects with pre-existing medical illnesses or medications which might interfere with the study as determined by pi.
boolean
C0521987 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial